2 DOSAGE AND ADMINISTRATION

Use within 60 days after reconstitution; discard any remainder after expiration.

• Some users may experience a blue-tinted visual effect temporarily.
• Sildenafil can cause a drop in blood pressure, which is dangerous for some.
• It is not recommended for women or children.
• Always follow the prescribed dose for safe use.

The liquid suspension is premixed and may contain flavoring.

Non-medical use

Salt stability can be related to factors such as melting point, solubility, hygroscopicity, and microenvironmental pH. [2] Pharmaceutical salts frequently exist as hydrates, which create difficulties during formulation development, particularly in wet granulation. It often becomes difficult to monitor and control the anhydrate/hydrate form during the wet mixing, fluid bed drying and aqueous film coating processes. This factor has led to the deselection of a particular salt form in further development process many times. A number of pivotal issues with respect to salt selection for basic drugs take into consideration the molecular and bulk properties of the material and the impact of the material as a salt form to the pharmacokinetics of the molecule.

Incidence not known

[4] If a salt has the tendency to form many polymorphs, then, unless production of the desired form can be easily controlled, it should be rejected in favour of one that exhibits less polymorphic behaviour. The decision of whether to develop a salt form or a free form of a drug must also include the cost and feasibility of making the desired form. The feasibility and ease of crystallization of a salt form could be an important factor in the salt selection decision. Since the crystallization process serves the important purpose of purifying a drug substance, a salt form with a higher degree of crystallinity will be preferred from the chemical processing perspective. A less-crystalline salt form may not readily provide the desired chemical purity and could require extensive effort and cost to develop a robust crystallization process.

Raynaud's phenomenon

In some cases, however, the most bioavailable form is developed, and appropriate manufacturing and storage conditions are implemented to minimize degradation and conversion to another form. The decision to investigate salt forms should be driven by the intended use and properties of the drug, such as the pKa, which will influence the selection of counterions used to make salts and the tendency of the salt form to disproportionate as well as other important factors such as economic viability etc [2] Adeyeye, Moji Christianah; Brittain Harry, G. (2008). Preformulation in Solid Dosage Form Development (Vol. New York, NY 10017: Informa Healthcare USA, Inc. Shake well before oral administration and use a calibrated measuring device for accurate dosing.

IV: Administer as an IV bolus injection; the supplied product is ready for use.

Society and culture

Safety and efficacy have not been established in patients with PAH younger than 1 year. Due to high plasma protein binding and poor elimination in urine, removal via hemodialysis is unlikely. Tablets: Administer orally with or without food. Reconstitute product before oral administration, and shake well before use. An oral syringe is recommended for dose measurement (and delivery). Tablets/IV solution: Store at 20C to 25C (68F to 77F); excursions permitted to 15C to 30C (59F to 86F).

Oral suspension (liquid): Store at 20C to 25C (68F to 77F); excursions permitted to 15C to 30C (59F to 86F). Oral suspension (powder): Store below 30C (86F) in the original package in order to protect from moisture.

Frequently asked questions

Expert Opinion on Drug Delivery, 10(9), 1239-1257. Fildena Double 200 is a medicine used to treat ED in men. It contains 200mg of the active ingredient Sildenafil, which increases blood flow to that area to help achieve and maintain ED Problems. The recommended dosage is one pill per day, but it is important to consult a doctor before taking it as it is a high dose and may not be suitable for everyone. Overdose can lead to serious side effects and it is important to follow precautions such as avoiding alcohol and driving while taking the medicine.

Revatio Tablets

It is not recommended for patients with heart, liver, or kidney disorders. Applies to the following strengths: 10 mg/mL; 10 mg/12.5 mL; 20 mg; 25 mg; 50 mg; 100 mg; 75 mg TABLETS (Viagra) Initial dose: 50 mg orally once a day, as needed, about 1 hour prior to sexual activity Maintenance dose: May increase to 100 mg or decrease to 25 mg once a day, based on efficacy and tolerability. Maximum dose: 100 mg orally once a day Comments: This drug may be taken anywhere from 30 minutes to 4 hours before sexual activity. TABLETS (Revatio)/ORAL SUSPENSION (Revatio, Liqrev): Initial dose: 20 mg orally 3 times a day Maintenance dose: May titrate up to 80 mg orally 3 times a day, if required, based on symptoms and tolerability. Maximum dose: 80 mg orally 3 times a day IV: 10 mg IV bolus 3 times a day Comments: No adjustment for body weight is required for IV dosing.

What happens with ED?

The 10 mg IV bolus dose is predicted to provide an equivalent pharmacological effect to that of 20 mg orally. Doses up to a maximum of 80 mg orally 3 times a day are supported by delayed clinical worsening with long-term use in clinical studies despite a lack of observed dose-response improvement in exercise ability in short-term clinical studies. In adults 65 years or older, use caution with dose selection due to a higher incidence of compromised renal, cardiac, and/or hepatic function, and of concomitant disease or drug therapy. Use: For the treatment of PAH (WHO Group I) to improve exercise ability and delay clinical worsening TABLETS (Viagra) Initial dose: 25 mg orally once a day, as needed, about 1 hour prior to sexual activity Maintenance dose: May titrate up to 100 mg orally once a day, based on effectiveness and toleration. Maximum dose: 100 sildenafil citrate tables mg orally once a day Comments: This drug may be administered anywhere from 30 minutes to 4 hours before sexual activity. After reconstitution, store below 30C (86F) or in refrigerator at 2C to 8C (36F to 46F); do not freeze.

Drug Label Information

A reduced starting dose is recommended in older adults due to higher systemic exposure as compared to younger adults. TABLETS (Revatio)/ORAL SUSPENSION (Revatio) 1 to less than 18 years: Weight 20 kg or less: 10 mg orally 3 times a day Weight greater than 20 kg to 45 kg: 20 mg orally 3 times a day Weight greater than 45 kg: 20 mg orally 3 times a day; dose may be titrated up to a maximum of 40 mg orally 3 times a day, if required, based on symptoms and tolerability Use: For the treatment of pulmonary arterial hypertension (WHO Group I) to improve exercise ability and, in pediatric patients too young to perform standard exercise testing, pulmonary hemodynamics thought to underlie improvements in exercise ERECTILE DYSFUNCTION: Mild to Moderate Renal Dysfunction (CrCl 30 to 80 mL/min): No adjustment recommended Severe Renal Dysfunction (CrCl less than 30 mL/min): Consider a starting dose of 25 mg orally once a day, about 1 hour prior to sexual activity Mild, Moderate, or Severe Renal Dysfunction (CrCl 80 to less than 30 mL/min): No adjustment recommended ERECTILE DYSFUNCTION: Mild, Moderate, or Severe Liver Dysfunction (Child-Pugh A, B, or C): Consider a starting dose of 25 mg orally once a day, about 1 hour prior to sexual activity. Mild or Moderate Liver Dysfunction (Child-Pugh A or B): No adjustment recommended Severe Liver Dysfunction (Child-Pugh C): Data not available in this population. Initiate treatment with 25 mg orally once a day, as needed, about 1 hour prior to sexual activity Patients should be stable on alpha blocker therapy prior initiating treatment with this drug. Administration with CYP450 3A4 Inhibitors (e.g., ketoconazole, itraconazole, saquinavir) or Erythromycin: Consider a starting dose of 25 orally once a day, as needed, about 1 hour prior to sexual activity.

Cialis Generic

Recommended dose: 25 mg orally, as needed, about 1 hour prior to sexual activity Maximum dose: 25 mg orally within a 48 hour period Known hypersensitivity to either the active component or to any of the ingredients; hypersensitivity reactions have been reported, including rash and urticaria In patients who are using a guanylate cyclase (GC) stimulators, such as riociguat; phosphodiesterase type 5 inhibitors (PDE5), including this drug, may potentiate the hypotensive effects of GC stimulators. In patients who are using nitric oxide donors such as organic nitrates or organic nitrites in any form either regularly and/or intermittently; this drug has been shown to potentiate the hypotensive effects of nitrates based on its mechanism of action After patients have taken this drug for ED, it is unknown when nitrates, if necessary, can be safely administered. Although plasma levels of this drug at 24 hours post-dose are much lower than at peak concentration, it is unknown whether nitrates can be safely co-administered at this time point. Concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension Concomitant use of riociguat, a guanylate cyclase stimulator; PDE5 inhibitors, including this drug, may potentiate the hypotensive effects of riociguat. Known hypersensitivity to either the active component or to any of the ingredients of the tablet, injection, or oral suspension; hypersensitivity reactions have been reported, including anaphylactic reaction, anaphylactic shock, and anaphylactoid reaction Safety and efficacy have not been established in patients with ED younger than 18 years. Oral suspension (powder): Reconstitute with water (total 90 mL) in separate additions; shake vigorously after each addition. Do not mix with other medications or flavoring; insert adaptor into bottle neck. Consult the manufacturer product information for detailed instructions.

• Sildenafil was first approved by the FDA in 1998.
• It revolutionized erectile dysfunction treatment worldwide.
• Research is ongoing into new potential uses of PDE5 inhibitors.
• The drug has helped millions improve their quality of life.

Cardiovascular: Cardiac status/risk factors (prior to initiation); blood pressure (periodically during treatment in patients with PAH on concomitant anti-hypertensive agents) Drug Interactions: For concomitant use of medications that may be contraindicated or for dose adjustment (at baseline and during treatment) Ocular: NAION risk factors (prior to initiation) Read the US FDA-approved patient labeling (Patient Information and/or Instructions for Use).